This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Limb Length Discrepancy
Phase
-
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to obtain post market performance and safety data of the Ellipse PRECICE Intramedullary Limb Lengthening System for subjects undergoing unilateral limb lengthening.

Provided treatments

  • Device: PRECICE System
Tris trial is registered with FDA with number: NCT01601301. The sponsor of the trial is Ellipse Technologies, Inc. and it is looking for 32 volunteers for the current phase.
Official trial title:
A Post-Market Prospective Evaluation of the Performance and Safety of the Ellipse PRECICE Intramedullary Limb Lengthening System